Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.0c01025
Abstract: HDACs are an attractive therapeutic target for a variety of human diseases. Currently, all four FDA-approved HDAC-targeting drugs are non-selective, pan-HDAC inhibitors, exhibiting adverse side-effects at therapeutic doses. While selective HDAC-inhibition has been proposed to…
read more here.
Keywords:
conformationally constrained;
hdac8;
benzanilide scaffolds;
scaffolds potent ... See more keywords